Product Information
DOXEPIN HCL 3 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $1.3644 per EA under NDC 72205005230. Its NADAC has been published 159 times since Aug 9, 2023.
FDA first approved this application on Apr 3, 2023. Its Orange Book therapeutic-equivalence code is BX.
Strength
3 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205005230
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214823FDA Approved
4/3/2023
TE Code
BX
On Market Since
4/5/2023
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN HCL 3 MG TABLET has been published 159 times since Aug 9, 2023, and over the history we have for it it has declined 82.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3644 per EA |
|---|---|
| All-time high | $8.1473 (Sep 13, 2023) |
| All-time low | $1.3271 (Jul 22, 2026) |
| 52-week high | $2.1099 |
| 52-week low | $1.3271 |
| Median price | $2.7240 |
| Average price | $3.1765 |
| Largest weekly change | -32.6% (Sep 20, 2023) |
| Weeks tracked | 159 |
| Tracking since | Aug 9, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Doxepin hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXEPIN HCL 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN HCL 3 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $1.3644 per EA (NDC 72205005230), effective Aug 19, 2026.
How has the price of DOXEPIN HCL 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOXEPIN HCL 3 MG TABLET has declined 82.5%. It has been tracked across 159 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for DOXEPIN HCL 3 MG TABLET?
Since Aug 9, 2023, the NADAC for DOXEPIN HCL 3 MG TABLET has ranged from a low of $1.3271 (Jul 22, 2026) to a high of $8.1473 (Sep 13, 2023), with a median of $2.7240 per EA.
Are there cheaper alternatives to DOXEPIN HCL 3 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DOXEPIN HCL 3 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXEPIN HCL 3 MG TABLET?
DOXEPIN HCL 3 MG TABLET (NDC 72205005230) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.